TY  - GEN
AU  - Balaña,Carmen
AU  - Capellades,Jaume
AU  - Pineda,Estela
AU  - Estival,Anna
AU  - Puig,Josep
AU  - Domenech,Sira
AU  - Verger,Eugenia
AU  - Pujol,Teresa
AU  - Martinez-García,Maria
AU  - Oleaga,Laura
AU  - Velarde,JoseMaria
AU  - Mesia,Carlos
AU  - Fuentes,Rafael
AU  - Marruecos,Jordi
AU  - Del Barco,Sonia
AU  - Villà,Salvador
AU  - Carrato,Cristina
AU  - Gallego,Oscar
AU  - Gil-Gil,Miguel
AU  - Craven-Bartle,Jordi
AU  - Alameda,Francesc
TI  - Pseudoprogression as an adverse event of glioblastoma therapy
SN  - 2045-7634
PY  - 2018///0129
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Brain Neoplasms
KW  - diagnostic imaging
KW  - Chi-Square Distribution
KW  - DNA Methylation
KW  - DNA Modification Methylases
KW  - DNA Repair Enzymes
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Female
KW  - Glioblastoma
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Magnetic Resonance Imaging
KW  - Male
KW  - Middle Aged
KW  - Odds Ratio
KW  - Polymerase Chain Reaction
KW  - Predictive Value of Tests
KW  - Proportional Hazards Models
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Spain
KW  - Time Factors
KW  - Treatment Outcome
KW  - Tumor Suppressor Proteins
KW  - Young Adult
N1  - Publication Type: Journal Article; Multicenter Study
UR  - https://doi.org/10.1002/cam4.1242
ER  -